A double blind trial of botulinum toxin "A" in torticollis, with one year follow up
- PMID: 1955900
- PMCID: PMC1014522
- DOI: 10.1136/jnnp.54.9.813
A double blind trial of botulinum toxin "A" in torticollis, with one year follow up
Abstract
A double blind placebo controlled crossover trial was performed of botulinum toxin "A" in 20 patients with spasmodic torticollis. There was a statistically significant benefit for those treated with toxin; 12 on toxin improved objectively, compared with four on placebo (p less than 0.04). After a follow up period of one year, 16 still seemed to benefit from repeated toxin injections. The main side effect was dysphagia, which appeared to be dose related in individual patients.
Similar articles
-
Botulinum toxin treatment in spasmodic torticollis.J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):640-3. doi: 10.1136/jnnp.53.8.640. J Neurol Neurosurg Psychiatry. 1990. PMID: 2213040 Free PMC article. Clinical Trial.
-
Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients.Mov Disord. 1991;6(2):145-50. doi: 10.1002/mds.870060210. Mov Disord. 1991. PMID: 2057005 Clinical Trial.
-
Effectiveness of botulinum toxin in the treatment of spasmodic torticollis.Eur Neurol. 1993;33(3):199-203. doi: 10.1159/000116936. Eur Neurol. 1993. PMID: 8467837
-
Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.J Formos Med Assoc. 1995 Apr;94(4):189-92. J Formos Med Assoc. 1995. PMID: 7606182 Review.
-
[Treatment of focal dystonia with botulinum toxin A].Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Wien Klin Wochenschr. 2001. PMID: 15506045 Review. German.
Cited by
-
Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.J Neurol Neurosurg Psychiatry. 1995 Dec;59(6):601-7. doi: 10.1136/jnnp.59.6.601. J Neurol Neurosurg Psychiatry. 1995. PMID: 7500097 Free PMC article. Clinical Trial.
-
Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.CNS Drugs. 2008;22(9):725-38. doi: 10.2165/00023210-200822090-00002. CNS Drugs. 2008. PMID: 18698873 Review.
-
Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.Ital J Neurol Sci. 1997 Oct;18(5):261-9. doi: 10.1007/BF02083302. Ital J Neurol Sci. 1997. PMID: 9412849 Review.
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2017 Dec 12;12(12):CD003633. doi: 10.1002/14651858.CD003633.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Nov 12;11:CD003633. doi: 10.1002/14651858.CD003633.pub4. PMID: 29230798 Free PMC article. Updated.
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2020 Nov 12;11(11):CD003633. doi: 10.1002/14651858.CD003633.pub4. Cochrane Database Syst Rev. 2020. PMID: 33180963 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources